CUR 61414

CAS : 334998-36-6

Ref. TR-C835000

Informations sur le produit

• Nom: CUR 61414
• Synonymes: N-[(3S,5S)-1-(1,3-benzodioxol-5-ylmethyl)-5-(piperazine-1-carbonyl)pyrrolidin-3-yl]-N-[(3-methoxyphenyl)methyl]-3,3-dimethylbutanamide

Description

Applications CUR 61414 is a proline derivative as mediator of hedgehog signaling pathways for pharmaceutical and cosmetic uses. CUR 61414 is a Nucleoside analog. CUR 61414 is an antimetabolite antitumor combination Gemcitabine cancer treatment.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Van der Riet, P., et al.: Cancer Res., 54, 25 (1994), Hahn, H., et al.: Cell, 85, 841 (1996), Johnson, R., et al.: Science, 272, 1668 (1996), Ingham, P., et al.: Genes Dev., 15, 3059 (2001),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 550.69
• Formule: C₃₁H₄₂N₄O₅
• Couleur/Forme: Neat
• InChI: InChI=1S/C31H42N4O5/c1-31(2,3)17-29(36)35(19-22-6-5-7-25(14-22)38-4)24-16-26(30(37)33-12-10-32-11-13-33)34(20-24)18-23-8-9-27-28(15-23)40-21-39-27/h5-9,14-15,24,26,32H,10-13,16-21H2,1-4H3/t24-,26-/m0/s1
• Code InChI: InChIKey=WPHXYKUPFJRJDK-AZGAKELHSA-N
• SMILES: COc1cccc(CN(C(=O)CC(C)(C)C)[C@H]2C[C@H](C(=O)N3CCNCC3)N(Cc3ccc4c(c3)OCO4)C2)c1